InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Smith Thomas B, Directeur Médical. Director active across 2 companies, notably Biodelivery Sciences International INC. In total, 9 filings have been logged. Split: 0 buy · 3 sells. Total volume traded: €926k. History available since 27 January 2022. The latest transaction was filed on 10 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Smith Thomas B is the Chief Medical Officer at BIODELIVERY SCIENCES INTERNATIONAL INC. He oversees the company's medical and clinical initiatives, ensuring that products and services meet quality and safety standards. His medical expertise is essential for the development of new therapies.